A detailed history of Catalytic Wealth Ria, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Catalytic Wealth Ria, LLC holds 8,710 shares of ABT stock, worth $906,014. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,710
Previous 6,926 25.76%
Holding current value
$906,014
Previous $762 Million 29.86%
% of portfolio
0.2%
Previous 0.34%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $195,383 - $215,792
1,784 Added 25.76%
8,710 $990 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $624,655 - $764,630
6,926 New
6,926 $762 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Catalytic Wealth Ria, LLC Portfolio

Follow Catalytic Wealth Ria, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalytic Wealth Ria, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalytic Wealth Ria, LLC with notifications on news.